Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis.

Louise B Callesen, Tana Takacova,Julian Hamfjord,Florian Würschmidt,Karl J Oldhafer,Roland Brüning,Dirk Arnold,Karen-Lise G Spindler

Therapeutic advances in medical oncology（2022）

Cited 4|Views14

No score

Abstract

Measurements of circulating DNA can be valuable when selecting and monitoring patients undergoing loco-regional treatment of CRC metastases. Studies designed to investigate the true clinical utility of circulating DNA in the context of various ablation modalities are warranted.The review has been registered at PROSPERO (ID: CRD42022320032).

Translated text

Key words

biomarker,cell-free DNA,circulating free DNA,circulating tumor DNA,loco-regional treatment,metastatic colorectal cancer

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined